Vium
Presence
Recursion Pharma is one of the...
Recursion Pharma is a company listed under the stock ticker RXRX (US).
Acquisition, funding and merger involving Recursion Pharma.
- Recursion Pharma has just announced a $50 Million fundraising (posted on July 17 2023).
- Recursion Pharma has announced the acquisition of Cyclica (posted on May 12 2023).
Executives
View the org chart displaying its 7 main executives
Most searched biographies at Vium
- Laura Schaevitz, Chief Executive Officer and Director
- Armen Vidian, Director
- Zachary Bogue, Director
Popular executive movements at Recursion Pharma
- Najat Khan has joined the company as Director, Chief R&D Officer and Chief Commercial Officer (posted on April 17 2024).
Create your alert
to follow the executive moves at Vium.
Pharmaceuticals
Recursion Pharma has 1,859 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- MedMen has filed for bankruptcy protection (posted on April 28 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
Popular contacts in Pharmaceuticals
News
Press releases by Vium
- http://vium.wpenginepowered.com/wp-content/uploads/2018/09/3Scan-Press-Release.pdf
- https://vium.wpenginepowered.com/wp-content/uploads/2019/10/Press-Release-AALAS_Vium-FINAL.pdf
Social media about Vium
- Vium on Wikipedia, Google News & Yahoo Finance
- Vium on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Zachary Bogue 
